![](/img/cover-not-exists.png)
Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy
Victor L. Serebruany, Alex I. Malinin, Kevin P. Callahan, Azan Binbrek, Frans Van de Werf, John H. Alexander, Christopher B. Granger, Paul A. GurbelVolume:
145
Year:
2003
Language:
english
DOI:
10.1067/mhj.2003.210
File:
PDF, 149 KB
english, 2003